A comprehensive pathological report is essential for optimal patient management, cancer
staging and prognostication. In many countries, proforma reports are used but these vary in …

Multimodal therapy concepts have been successfully implemented in the treatment of locally
advanced gastrointestinal malignancies. The effects of neoadjuvant chemo-or …

Purpose We previously described the prognostic impact of tumor regression grading (TRG)
on the outcome of patients with rectal carcinoma treated with preoperative …

Purpose To develop and validate a histopathologic scoring system for measuring response
to neoadjuvant chemotherapy in interval debulking surgery specimens of stage IIIC to IV …

Background Tumor regression grade (TRG) is a measure of histopathological response of
rectal cancer to neoadjuvant chemoradiation and is associated with outcomes. Several TRG …

Background Neoadjuvant chemoradiotherapy (CRT) has been proven to increase local
control in rectal cancer, but the optimal interval between CRT and surgery is still unclear …

Background: Limited data exist regarding the correlation between MRI tumour regression
grade (mrTRG) and pathological TRG (pTRG) in rectal cancer. Methods: mrTRG and pTRG …

Background and purpose Neoadjuvant radiotherapy (RT) in rectal cancer induces tumour
regression with a possible complete response (pCR). The optimal fractionation and timing to …

Purpose Tumor regression grade (TRG) is predictive of therapeutic response in rectal
cancer patients after chemoradiotherapy (CRT) followed by curative resection. However …

Neoadjuvant therapy has been successfully introduced in the treatment of locally advanced
gastrointestinal malignancies, particularly esophageal, gastric, and rectal cancers. The …